Milestone Scientific Inc. reports developments tied to computerized drug delivery instruments for dental and medical applications. The company’s Dynamic Pressure Sensing technology supports pressure-guided injection and fluid-aspiration procedures, including dental anesthesia delivery through The Wand STA system and medical applications such as CompuFlo for controlled epidural injections.
Recurring news themes include financial results, business-update calls, commercialization programs, physician and dental-practice adoption, distributor and reimbursement infrastructure, international product registrations, disposable utilization, operating expense initiatives, and capital actions involving common stock and warrants.
Milestone Scientific Inc. (MLSS) announced a conference call on August 17, 2020, at 8:30 AM ET, to discuss its financial results for Q2 2020 ending June 30. The call aims to cover corporate progress and developments. Investors can participate via the company's website or by telephone. A replay will be available within an hour after the call until August 31, 2020. Milestone Scientific focuses on innovative drug delivery instruments that enhance injection precision and comfort, utilizing its proprietary Dynamic Pressure Sensing technology.
Milestone Scientific (NYSE American: MLSS) has announced a conference call scheduled for August 17, 2020, at 8:30 AM ET to discuss its financial results for Q2 2020 and corporate developments. Interested parties can access the call via the company's website or by dialing the appropriate toll-free numbers. The call will also be archived for later access. Milestone specializes in innovative injection technologies aimed at providing painless and precise injections, utilizing their proprietary DPS Dynamic Pressure Sensing technology.